Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns
On-Demand Webinar
Improve pediatric drug development with Certara’s Pediatric Practice, MIDD expertise for PIPs/PSPs, dose selection, regulatory…